Patents by Inventor Kanhaiya SINGH

Kanhaiya SINGH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EPIGENETIC MODULATORS FOR TISSUE REPROGRAMMING
    Publication number: 20240335563
    Abstract: Disclosed herein are compositions and in vitro and in vivo methods for reducing diabetes-induced epigenetic barriers in cells to enhance the efficacy of treatments of diabetes.
    Type: Application
    Filed: August 11, 2022
    Publication date: October 10, 2024
    Inventors: Chandan K. SEN, Manishekhar KUMAR, Kanhaiya SINGH, Sashwati ROY
  • COMPOSITIONS AND METHODS FOR REPROGRAMMING SKIN TISSUE TO HAVE INSULINOGENIC AND DELIVERY FUNCTIONS
    Publication number: 20230218780
    Abstract: Disclosed herein are compositions and in vitro and in vivo methods for reprogramming post-natal (adult and juvenile) tissue into insulinogenic cells. These compositions and methods are useful for a variety of purposes, including the development of diabetes therapies.
    Type: Application
    Filed: June 25, 2021
    Publication date: July 13, 2023
    Inventors: Chandan K. SEN, Sashwati ROY, Manishekhar KUMAR, Kanhaiya SINGH
  • VASCULOGENIC FIBROBLASTS
    Publication number: 20220333107
    Abstract: Compositions and methods are provided for reprogramming dermal fibroblasts to exhibit vasculogenic properties including the ability to stimulate vasculogenesis in vivo. In accordance with one embodiment such compositions are used in conjunction with standard treatment for use on chronic wounds including in diabetic patients.
    Type: Application
    Filed: September 18, 2020
    Publication date: October 20, 2022
    Inventors: Chandan K. SEN, Kanhaiya SINGH, Sashwati ROY, Mervin C. YODER, Saba TABASUM, Ahmed Safwat ABOU-HASHEM, Subhadip GHATAK